A single center study of 25 subjects to assess the addition of Enstilar Foam in patients receiving Taltz for 24 weeks with BSA between 3% and 8%.
A single center study of 25 subjects to assess the addition of Enstilar Foam in patients receiving Taltz for 24 weeks with BSA between 3% and 8%.
NCT04372277
Psoriasis Treatment Center of Central New Jersey
19 February 2024
Congrats! You have your own personal workspace now.